Liege, Belgium – 09 September 2026 (08:30 CET) – Allegro NV, a biomedical company developing a transformative nanotechnology treatment for osteoarthritis, today […]
Allegro rapporteert bemoedigende klinische resultaten met gepatenteerde injecteerbare nanotechnologie voor knieartrose • Hydrocelin werd inmiddels geëvalueerd bij 50 patiënten met knieartrose, waaronder […]
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 12 […]
Liege, Belgium – 9 January 2026 (08:30 CET) – Allegro NV, a biomedical company developing transformative injectable, mechanically-acting devices for osteoarthritis, will […]
Liege, Belgium and Shirley, NY – 25 November 2025 (08:30 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based devices for […]
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 7 […]
Liege, Belgium – 3 September 2025 (08:30) – Allegro NV, a biomedical company developing transformative devices for degenerative joint disease, has appointed […]
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 3 […]
Allegro was featured in the Noshaq Stories this month with a full feature article in French. Read the full article below or […]
Liege, Belgium – 11 April 2025 (17:00 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for osteoarthritis, today presented […]